Related Experiment Video
Updated: Feb 5, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
[Establishment of retinal disease models using non-human primates and its strategy for drug discovery]
Masamitsu Shimazawa1, Hideaki Hara1
1Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University.
Abstract:
Retinal diseases such as glaucoma, diabetic retinopathy, age-related macular degeneration and retinitis pigmentosa are the major causes of blindness. However, these pathological mechanisms remain to be elucidated, and development of new therapeutic agents has been desired. A large number of experimental animal models using rodents (rats and mice) have been used for the evaluations of the pathogenesis and novel therapeutic candidates in retinal diseases. However, the anatomy of the retina in rodents is different from that in humans, as rodents have no macular. Conversely, non-human primates have macular similar to humans, and therefore rhesus and cynomolgus monkeys are widely used as experimental animal models of retinal diseases. Here, we will introduce non-human primate models of retinal diseases and their pharmacological approaches, with a focus on our research findings.
Related Concept Videos
Drug Discovery: Overview
Clinically Relevant Drug Product Specifications: Methods of Establishment
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...

